Evidence map›Paper›PMID 40114955›Full record

ArticleTranslational lung cancer research2025

Pathologic complete response following salvage surgery after lazertinib treatment in advanced

Chanmi Kim, Jongsoo Park, Jang Hoon Lee, Seong Yong Jeong, June Hong Ahn

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chanmi Kim *Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jongsoo Park *Department of Radiology, Yeungnam University Medical Center, College of Medicine, Yeungnam University, Daegu, Republic of Korea.ORCID https://orcid.org/0000-0001-7204-6700
Jang Hoon LeeDepartment of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University, Daegu, Republic of Korea.
Seong Yong JeongDepartment of Ophthalmology, Yeungnam University College of Medicine, Daegu, Republic of Korea.ORCID https://orcid.org/0000-0001-9175-9642
June Hong AhnDivision of Pulmonology and Allergy, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea.ORCID https://orcid.org/0000-0001-7104-8325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Salvage surgery following epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor therapy is a viable treatment option for selected patients with initially unresectable non-small cell lung cancer (NSCLC) harboring Case Description: We herein describe a 63-year-old man who presented to the emergency department with a 1-week history of speech disturbance and was diagnosed with clinical stage T1cN2M1b, IVA NSCLC with an Conclusions: This case suggests that salvage surgery after treatment with lazertinib may be a safe and effective approach for NSCLC with common

Indexed as

adenocarcinoma of lungcase reportepidermal growth factor receptor (EGFR)lazertinibPathologic complete response (pCR)

Identifiers

PMID40114955
PMCPMC11921380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.